Wolverine Trading
LGND icon

Wolverine Trading’s Ligand Pharmaceuticals LGND Stock Holding History

Wolverine Trading’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,500
Closed -$377K – 5219
2025
Q1 		$377K Buy
+3,500
New +$396K ﹤0.01% 3286
2022
Q1 		– Sell
-4,649
Closed -$453K – 5990
2021
Q4 		$453K Sell
4,649
-1,122
-19% -$104K ﹤0.01% 3595
2021
Q3 		$504K Buy
+5,771
New +$446K ﹤0.01% 3922
2020
Q1 		– Sell
-19,396
Closed -$1.26M – 4963
2019
Q4 		$1.26M Sell
19,396
-21,160
-52% -$1.41M ﹤0.01% 2199
2019
Q3 		$2.5M Sell
40,556
-10,580
-21% -$664K 0.01% 1282
2019
Q2 		$3.64M Sell
51,136
-42,640
-45% -$3.14M 0.01% 1105
2019
Q1 		$7.35M Buy
93,776
+12,023
+15% +$911K 0.02% 655
2018
Q4 		$6.93M Buy
+81,753
New +$8.72M 0.02% 622
2018
Q1 		– Sell
-4,008
Closed -$342K – 5499
2017
Q4 		$342K Buy
4,008
+1,123
+39% +$97.3K ﹤0.01% 3437
2017
Q3 		$245K Buy
+2,885
New +$228K ﹤0.01% 3549
2017
Q2 		– Sell
-19,236
Closed -$1.26M – 4663
2017
Q1 		$1.26M Buy
+19,236
New +$1.27M 0.01% 1547
2016
Q4 		– Sell
-15,870
Closed -$1.01M – 4823
2016
Q3 		$1.01M Sell
15,870
-5,129
-24% -$377K ﹤0.01% 1843
2016
Q2 		$1.59M Buy
+20,999
New +$1.56M 0.01% 1262

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's LGND Position: Q2 2025 in Review

Wolverine Trading sold out of Ligand Pharmaceuticals (LGND) in Q2 2025, closing a stake of 1,974 shares — an estimated $212K sold.

Wolverine Trading first reported a position in LGND in Q4 2018 and held it in 7 quarters. The position peaked at $4.26M in Q1 2019. 271 funds tracked by Wall St. Rank hold LGND as of Q2 2025.

  • Wolverine Trading reported no remaining Ligand Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 1,974 Ligand Pharmaceuticals shares in Q2 2025, an estimated $212K.
  • Wolverine Trading first reported a position in Ligand Pharmaceuticals in Q4 2018 and held it in 7 quarters.
  • Wolverine Trading's Ligand Pharmaceuticals position peaked at $4.26M in Q1 2019.
  • 271 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.